Question 8868 — maternity health insurance

Summary

Mr. Philippe Michel-Kleisbauer draws the attention of the Minister of Solidarity and Health to the management of sexual difficulties encountered by women with cancer in France. Indeed, whether they are menopausal naturally before the start of treatments or early following treatments for the youngest, they present an increased risk of estrogen deficiency compared to the general population, whose induced effects are a source of a deterioration in their quality of life (hot flashes, vulvovaginal disorders, psychological disorders, etc.). The consequences can be serious: stopping hormone therapy, self-devaluation, depression, marital difficulties. However, hormonal replacement treatments, which are reimbursed by social security, are contraindicated by the National Cancer Institute in cases of known or suspected breast cancer, or other known or suspected estrogen-dependent tumors. Alternative medications and medical devices exist, but they are expensive and not covered, imposing very significant out-of-pocket costs on these women over very long periods of time. Action 18 of the implementation plan of the national sexual health strategy of the Ministry of Health announces "the management of possible sexual difficulties among patients suffering from chronic illnesses. He therefore asks what measures are being considered to allow reimbursement of at least one hormone-free menopause treatment for women with a history of cancer.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.